Freedman Financial Associates’s CryoPort CYRX Stock Holding History

Freedman Financial Associates’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-260	Closed	-$9K	–	87
2022 Q1	$9K	Buy	+260	New	+$9.83K	0.01%	366

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Freedman Financial Associates's CYRX Position: Q2 2022 in Review

Freedman Financial Associates sold out of CryoPort (CYRX) in Q2 2022, closing a stake of 260 shares — an estimated $9K sold.

Freedman Financial Associates first reported a position in CYRX in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2022.

Freedman Financial Associates reported no remaining CryoPort position as of Q2 2022 after selling out during the quarter.
Freedman Financial Associates sold 260 CryoPort shares in Q2 2022, an estimated $9K.
Freedman Financial Associates first reported a position in CryoPort in Q1 2022 and held it in 1 quarter.
Freedman Financial Associates's CryoPort position peaked at $9K in Q1 2022.
184 funds tracked by Wall St. Rank held CryoPort as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.